Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: Relationship to neuropsychiatric symptoms

Arthritis Research and Therapy

Volumn 10, Issue 4, 2008, Pages

  George Chandy, Annie ^a,b   Trysberg, Estelle ^c   Eriksson, Kristina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; AUTOANTIBODY; B CELL ACTIVATING FACTOR OF TUMOR NECROSIS FACTOR FAMILY; INTERLEUKIN 6; TUMOR NECROSIS FACTOR DERIVATIVE; B CELL ACTIVATING FACTOR; TNFSF13B PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BIOASSAY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN SYNTHESIS; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; BRAIN VASCULITIS; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; B-CELL ACTIVATING FACTOR; BLOOD-BRAIN BARRIER; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; YOUNG ADULT;

EID: 51349106593     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2484     Document Type: Article

References (67)

1. Von Feldt JM Systemic lupus erythematosus. Recognizing its various presentations Postgrad Med 1995, 97:79, 83, 86 passim. 7716094
2. Uramoto KM Michet CJ Jr Thumboo J Sunku J O'Fallon WM Gabriel SE Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992 Arthritis Rheum 1999, 42:46-50 9920013
3. Hanly JG Neuropsychiatric lupus Rheum Dis Clin North Am 2005, 31:273-298 vi. 15922146
4. Boumpas DT Yamada H Patronas NJ Scott D Klippel JH Balow JE Pulse cyclophosphamide for severe neuropsychiatric lupus Q J Med 1991, 81:975-984 1808642
5. Oku K Atsumi T Furukawa S Horita T Sakai Y Jodo S Amasaki Y Ichikawa K Amengual O Koike T Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement Rheumatology (Oxford) 2003, 42:773-777 12730538
6. Alcocer-Varela J Aleman-Hoey D Alarcon-Segovia D Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers Lupus 1992, 1:111-117 1301962
7. Hirohata S Tanimoto K Ito K Elevation of cerebrospinal fluid interleukin-6 activity in patients with vasculitides and central nervous system involvement Clin Immunol Immunopathol 1993, 66:225-229 8432047
8. Trysberg E Blennow K Zachrisson O Tarkowski A Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement Arthritis Res Ther 2004, 6:R551-556 1064867 15535833
9. Svenungsson E Andersson M Brundin L van Vollenhoven R Khademi M Tarkowski A Greitz D Dahlstrom M Lundberg I Klareskog L Olsson T Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus Ann Rheum Dis 2001, 60:372-379 1753603 11247868
10. Trysberg E Nylen K Rosengren LE Tarkowski A Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement Arthritis Rheum 2003, 48:2881-2887 14558094
11. Dillon SR Gross JA Ansell SM Novak AJ An APRIL to remember: Novel TNF ligands as therapeutic targets Nat Rev Drug Discov 2006, 5:235-246 16474316
12. Mackay F Schneider P Rennert P Browning J BAFF and APRIL: A tutorial on B cell survival Annu Rev Immunol 2003, 21:231-264 12427767
13. Lopez-Fraga M Fernandez R Albar JP Hahne M Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase EMBO Rep 2001, 2:945-951 1084076 11571266
14. Marsters SA Yan M Pitti RM Haas PE Dixit VM Ashkenazi A Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI Curr Biol 2000, 10:785-788 10898980
15. Thompson JS Bixler SA Qian F Vora K Scott ML Cachero TG Hession C Schneider P Sizing ID Mullen C Strauch K Zafari M Benjamin CD Tschopp J Browning JL Ambrose C BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF Science 2001, 293:2108-2111 11509692
16. Yan M Brady JR Chan B Lee WP Hsu B Harless S Cancro M Grewal IS Dixit VM Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency Curr Biol 2001, 11:1547-1552 11591325
17. Ingold K Zumsteg A Tardivel A Huard B Steiner QG Cachero TG Qiang F Gorelik L Kalled SL Acha-Orbea H Rennert PD Tschopp J Schneider P Identification of proteoglycans as the APRIL-specific binding partners J Exp Med 2005, 201:1375-1383 2213192 15851487
18. Seyler TM Park YW Takemura S Bram RJ Kurtin PJ Goronzy JJ Weyand CM BLyS and APRIL in rheumatoid arthritis J Clin Invest 2005, 115:3083-3092 1257539 16239971
19. Jonsson MV Szodoray P Jellestad S Jonsson R Skarstein K Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome J Clin Immunol 2005, 25:189-201 15981083
20. Stohl W Metyas S Tan SM Cheema GS Oamar B Xu D Roschke V Wu Y Baker KP Hilbert DM B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations Arthritis Rheum 2003, 48:3475-3486 14673998
21. Stohl W BlySfulness does not equal blissfulness in systemic lupus erythematosus: A therapeutic role for BLyS antagonists Curr Dir Autoimmun 2005, 8:289-304 15564726
22. Koyama T Tsukamoto H Masumoto K Himeji D Hayashi K Harada M Horiuchi T A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus Rheumatology (Oxford) 2003, 42:980-985 12730512
23. Mackay F Woodcock SA Lawton P Ambrose C Baetscher M Schneider P Tschopp J Browning JL Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations J Exp Med 1999, 190:1697-1710 2195729 10587360
24. Schiemann B Gommerman JL Vora K Cachero TG Shulga-Morskaya S Dobles M Frew E Scott ML An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway Science 2001, 293:2111-2114 11509691
25. Cheema GS Roschke V Hilbert DM Stohl W Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases Arthritis Rheum 2001, 44:1313-1319 11407690
26. Groom J Kalled SL Cutler AH Olson C Woodcock SA Schneider P Tschopp J Cachero TG Batten M Wheway J Mauri D Cavill D Gordon TP Mackay CR Mackay F Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome J Clin Invest 2002, 109:59-68 150825 11781351
27. Zhang J Roschke V Baker KP Wang Z Alarcon GS Fessler BJ Bastian H Kimberly RP Zhou T Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus J Immunol 2001, 166:6-10 11123269
28. Stein JV Lopez-Fraga M Elustondo FA Carvalho-Pinto CE Rodriguez D Gomez-Caro R De Jong J Martinez AC Medema JP Hahne M APRIL modulates B and T cell immunity J Clin Invest 2002, 109:1587-1598 151011 12070306
29. Castigli E Scott S Dedeoglu F Bryce P Jabara H Bhan AK Mizoguchi E Geha RS Impaired IgA class switching in APRIL-deficient mice Proc Natl Acad Sci USA 2004, 101:3903-3908 374342 14988498
30. Varfolomeev E Kischkel F Martin F Seshasayee D Wang H Lawrence D Olsson C Tom L Erickson S French D Schow P Grewal IS Ashkenazi A APRIL-deficient mice have normal immune system development Mol Cell Biol 2004, 24:997-1006 321448 14729948
31. Mackay F Sierro F Grey ST Gordon TP The BAFF/APRIL system: An important player in systemic rheumatic diseases Curr Dir Autoimmun 2005, 8:243-265 15564724
32. Schaller M Stohl W Tan SM Benoit VM Hilbert DM Ditzel HJ Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis Ann Rheum Dis 2005, 64:743-749 1755497 15458959
33. Thangarajh M Masterman T Helgeland L Rot U Jonsson MV Eide GE Pirskanen R Hillert J Jonsson R The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis J Neuroimmunol 2006, 178:161-166 16820216
34. Thangarajh M Masterman T Rot U Duvefelt K Brynedal B Karrenbauer VD Hillert J Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis J Neuroimmunol 2005, 167:210-214 16087247
35. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1997, 40:1725 9324032
36. Breitbach SA Alexander RW Daltroy LH Liang MH Boll TJ Karlson EW Partiridge AJ Roberts WN Stern SH Wacholtz MC Straaton KV Determinants of cognitive performance in systemic lupus erythematosus J Clin Exp Neuropsychol 1998, 20:157-166 9777469
37. Helle M Boeije L Aarden LA Functional discrimination between interleukin 6 and interleukin 1 Eur J Immunol 1988, 18:1535-1540 3263920
38. Aarden LA De Groot ER Schaap OL Lansdorp PM Production of hybridoma growth factor by human monocytes Eur J Immunol 1987, 17:1411-1416 3500054
39. Tarkowski E Rosengren L Blomstrand C Wikkelso C Jensen C Ekholm S Tarkowski A Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke Stroke 1995, 26:1393-1398 7631343
40. Trysberg E Carlsten H Tarkowski A Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement Lupus 2000, 9:498-503 11035414
41. Koyama T Tsukamoto H Miyagi Y Himeji D Otsuka J Miyagawa H Harada M Horiuchi T Raised serum APRIL levels in patients with systemic lupus erythematosus Ann Rheum Dis 2005, 64:1065-1067 1755547 15576416
42. Thangarajh M Masterman T Hillert J Moerk S Jonsson R A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis Scand J Immunol 2007, 65:92-98 17212772
43. Krumbholz M Theil D Derfuss T Rosenwald A Schrader F Monoranu CM Kalled SL Hess DM Serafini B Aloisi F Wekerle H Hohlfeld R Meinl E BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma J Exp Med 2005, 201:195-200 2212784 15642740
44. Mackay F Ambrose C The TNF family members BAFF and APRIL: The growing complexity Cytokine Growth Factor Rev 2003, 14:311-324 12787568
45. Weller RO Engelhardt B Phillips MJ Lymphocyte targeting of the central nervous system: A review of afferent and efferent CNS-immune pathways Brain Pathol 1996, 6:275-288 8864284
46. Alexander EL Murphy ED Roths JB Alexander GE Congenic autoimmune murine models of central nervous system disease in connective tissue disorders Ann Neurol 1983, 14:242-248 6625539
47. Zameer A Hoffman SA B and T cells in the brains of autoimmune mice J Neuroimmunol 2004, 146:133-139 14698855
48. Moore PA Belvedere O Orr A Pieri K LaFleur DW Feng P Soppet D Charters M Gentz R Parmelee D Li Y Galperina O Giri J Roschke V Nardelli B Carrell J Sosnovtseva S Greenfield W Ruben SM Olsen HS Fikes J Hilbert DM BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator Science 1999, 285:260-263 10398604
49. Nardelli B Belvedere O Roschke V Moore PA Olsen HS Migone TS Sosnovtseva S Carrell JA Feng P Giri JG Hilbert DM Synthesis and release of B-lymphocyte stimulator from myeloid cells Blood 2001, 97:198-204 11133761
50. Desai-Mehta A Lu L Ramsey-Goldman R Datta SK Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production J Clin Invest 1996, 97:2063-2073 507281 8621796
51. Llorente L Richaud-Patin Y Fior R Alcocer-Varela J Wijdenes J Fourrier BM Galanaud P Emilie D In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity Arthritis Rheum 1994, 37:1647-1655 7980676
52. Ronnblom L Eloranta ML Alm GV The type I interferon system in systemic lupus erythematosus Arthritis Rheum 2006, 54:408-420 16447217
53. Lipsky PE Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity Nat Immunol 2001, 2:764-766 11526379
54. Jego G Pascual V Palucka AK Banchereau J Dendritic cells control B cell growth and differentiation Curr Dir Autoimmun 2005, 8:124-139 15564719
55. Wan S Zhou Z Duan B Morel L Direct B cell stimulation by dendritic cells in a mouse model of lupus Arthritis Rheum 2008, 58:1741-1750 18512810
56. Jego G Palucka AK Blanck JP Chalouni C Pascual V Banchereau J Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6 Immunity 2003, 19:225-234 12932356
57. Kanakaraj P Migone TS Nardelli B Ullrich S Li Y Olsen HS Salcedo TW Kaufman T Cochrane E Gan Y Hilbert DM Giri J BLyS binds to B cells with high affinity and induces activation of the transcription factor NF-kappaB and ELF-1 Cytokine 2001, 13:25-31 11145839
58. Wu Y Bressette D Carrell JA Kaufman T Feng P Taylor K Gan Y Cho YH Garcia AD Gollatz E Dimke D LaFleur D Migone TS Nardelli B Wei P Ruben SM Ullrich SJ Olsen HS Kanakaraj P Moore PA Baker KP Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS J Biol Chem 2000, 275:35478-35485 10956646
59. Roschke V Sosnovtseva S Ward CD Hong JS Smith R Albert V Stohl W Baker KP Ullrich S Nardelli B Hilbert DM Migone TS BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases J Immunol 2002, 169:4314-4321 12370363
60. Tokunaga M Saito K Kawabata D Imura Y Fujii T Nakayamada S Tsujimura S Nawata M Iwata S Azuma T Mimori T Tanaka Y Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system Ann Rheum Dis 2007, 66:470-475 17107983
61. Lavie F Miceli-Richard C Ittah M Sellam J Gottenberg JE Mariette X Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: Insights into a new regulating system of BAFF production Ann Rheum Dis 2007, 66:700-703 17040963
62. Huntington ND Tomioka R Clavarino C Chow AM Linares D Mana P Rossjohn J Cachero TG Qian F Kalled SL Bernard CC Reid HH A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses Int Immunol 2006, 18:1473-1485 16914508
63. Thien M Phan TG Gardam S Amesbury M Basten A Mackay F Brink R Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches Immunity 2004, 20:785-798 15189742
64. Cohen SB Updates from B Cell Trials: Efficacy J Rheumatol 2006, 77:12-17 16652440
65. Dörner T Burmester GR New approaches of B-cell-directed therapy: beyond rituximab Curr Opin Rheumatol 2008, 20:263-268 18388516
66. Gross JA Dillon SR Mudri S Johnston J Littau A Roque R Rixon M Schou O Foley KP Haugen H McMillen S Waggie K Schreckhise RW Shoemaker K Vu T Moore M Grossman A Clegg CH TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS Immunity 2001, 15:289-302 11520463
67. Gross JA Johnston J Mudri S Enselman R Dillon SR Madden K Xu W Parrish-Novak J Foster D Lofton-Day C Moore M Littau A Grossman A Haugen H Foley K Blumberg H Harrison K Kindsvogel W Clegg CH TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease Nature 2000, 404:995-999 10801128